Rise Biopharmaceuticals, Inc.
π¨π³China
- Country
- π¨π³China
- Ownership
- Private, Subsidiary
- Established
- 2013-12-02
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Pancreatic CancerPancreatic Cancer MetastaticPancreatic Cancer Non-resectable
- Interventions
- First Posted Date
- 2020-04-08
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Rise Biopharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04338763
- Locations
- π¨π³
Chi Mei Hospital, Liouying, Tainan, Taiwan
π¨π³National Cheng Kung University Hospital, Tainan, Taiwan
News
No news found